NCT01335724 Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain Status COMPLETED Phase PHASE4
NCT01332396 Drug Use Investigation for TYKERB Tablet (All Case Investigation) Status COMPLETED Phase N/A
NCT01332097 Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation Status COMPLETED Phase PHASE2
NCT01329900 Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas Status COMPLETED Phase PHASE2
NCT01329289 SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT01324635 Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors Status TERMINATED Phase PHASE1
NCT01321346 A Study Of Panobinostat In Children With Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT01317875 Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF) Status COMPLETED Phase PHASE1
NCT01306981 Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study Status COMPLETED Phase PHASE4
NCT01298934 LBH589 (Panobinostat) for the Treatment of Myelofibrosis Status UNKNOWN Phase PHASE1/PHASE2
NCT01298713 Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer Status COMPLETED Phase PHASE2
NCT01283789 Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT01283334 A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01281657 Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program Status COMPLETED Phase N/A
NCT01275586 Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Status COMPLETED Phase EARLY_PHASE1
NCT01273610 Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01272947 Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries Status COMPLETED Phase PHASE3